<DOC>
	<DOCNO>NCT00554177</DOCNO>
	<brief_summary>purpose study test whether medication , call mifepristone ( commonly know ³Morning-After-Pill² ) , help prevent emotional problem someone survive traumatic experience . We study medication treatment Post-traumatic Stress disorder ( PTSD .</brief_summary>
	<brief_title>A Clinical Trial Post Traumatic Stress Disorder</brief_title>
	<detailed_description>PTSD emotional illness develop people experience traumatic event . It involve symptom poor sleep , nightmare trauma , unwanted daytime memory trauma ( flashback ) , jumpiness , trouble look forward thing future . Once people develop PTSD , symptom tend last long time . We test idea mifepristone , block effect hormones progesterone cortisol , help treat PTSD . Progesterone hormone make body men woman main role regulate menstrual cycle pregnancy . Cortisol also hormone make body men woman help body respond stress . Cortisol also role make emotional memory intense memory . We test whether block effect cortisol mifepristone recall trauma may able decrease intensity traumatic memory . This medication completely block memory traumatic experience may decrease much thought draw back memory traumatic event .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Male Female Between 18 65 year old Have experience one traumatic event within last year €Examples traumatic event include physical sexual assault , combat , natural disaster , witness death injury another person , bereavement €Currently experience severe symptom anxiety include flashback intrusive memory traumatic event . €Not currently pregnant intend become pregnant . If sexually active , participant must use approved form birth control Medically healthy Not currently take psychiatric medication &gt; Lifetime current diagnosis schizophrenia psychotic disorder , bipolar disorder , current Axis I disorder ( except major depression secondary PTSD ) Current evidence history significant unstable medical illness organic brain impairment , include stroke , CNS tumor , demyelinate disease , cardiac , pulmonary , gastrointestinal , renal hepatic impairment . Patient investigator¹s judgment pose current suicidal homicidal risk DSMIV substance abuse dependence within past 90 day Patient take psychotropic medication last 2 week ( 5 week fluoxetine ) prior screen . Psychotropic medication last 2 week prior screen , fluoxetine last 5 week . Treatment concomitant medication primarily CNS activity Treatment medication PI consider acceptable study . Patient regularly , average , drink ) 28 unit alcohol per week male patient , b ) 21 unit alcohol per week female patient ( 1 unit = 1/2 pint beer , 1 glass wine , 1 measure spirit ) Pregnancy lactation* Patient currently receive evidencedbased structured psychotherapy ( e.g. , cognitivebehavioral therapy , exposure therapy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>sexual</keyword>
	<keyword>combat</keyword>
	<keyword>PTSD</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Trauma</keyword>
	<keyword>PTSD treatment</keyword>
	<keyword>PTSD medication</keyword>
	<keyword>Post traumatic stress disorder</keyword>
</DOC>